Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

SCLX US Equity

Scilex Holding CoHealth Care · Biological Products, (No Diagnostic Substances) · CIK 1820190 · FY ends Dec 31
$5.73
-0.07 (-1.21%)
USD · as of 2026-08-21 · marketstack

SCLX · 10-K · period ended 2021-12-31

← all SCLX documents
filed 2022-02-24 · EDGAR original ↗

Our rendering of the filing — original pagination and typography are not reproduced, and tables are reduced to their short label cells (the figures live on FA). Nothing is summarized: every line below is the filing's own text.

blocks 1600 of 3,183291k characters rendered

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

☒Annual Report Pursuant to Section

13 or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended December 31, 2021

Commission File Number 001-39852

VICKERS VANTAGE CORP. I

Cayman Islands 6770 N/A

1 Harbourfront Avenue,

#16-06

Keppel Bay Tower, Singapore098632

Singapore

(Address of Principal Executive Offices)

Registrant’s

telephone number, including area code: (646)974-8301

Securities registered pursuant to Section 12(b)

of the Act:

Title of Each Class Trading Symbol(s) Name of each exchange on which registered

Ordinary Shares, par value $0.0001 per share VCKA The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g)

of the Act: None

Indicate by check mark if the registrant is a

well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not

required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes ☐ No ☒

Indicate by check mark whether the registrant

(1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the past 12 months (or for such

shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirement for the past

90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant

has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during

the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant

is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.

See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”

and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐

Non-accelerated filer ☒ Smaller reporting company ☒

Emerging growth company ☒

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate

by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of

its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public

accounting firm that prepared or issued its audit report. ☐

Indicate by check mark whether the registrant

is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of June 30, 2021, the last business day of the registrant’s

most recently completed second fiscal quarter, the aggregate market value of the voting and non-voting common equity held by non-affiliates

was $136,896,000 (based on the last sales price of the registrant’s ordinary shares on such date of $9.92).

As of February 24, 2022, 17,250,000

ordinary shares, par value $0.0001 per share, were issued and outstanding.

Documents Incorporated by Reference: None.

VICKERS VANTAGE CORP. I

FORM 10-K

TABLE OF CONTENTS

PART I

Item 1. Business 1

Item 1A. Risk Factors 8

Item 1B. Unresolved Staff Comments 35

Item 2. Properties 35

Item 3. Legal Proceedings 35

Item 4. Mine Safety Disclosures 35

PART II

Item 6. [Reserved] 37

Item 7A. Quantitative and Qualitative Disclosures About Market Risk 40

Item 8. Financial Statements and Supplementary Data 41

Item 9A. Controls and Procedures 41

Item 9B. Other Information 41

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspection 41

PART III

Item 10. Directors, Executive Officers and Corporate Governance 42

Item 11. Executive Compensation 46

Item 14. Principal Accounting Fees and Services 50

PART IV

Item 15. Exhibits, Financial Statement Schedules 51

i

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS;

SUMMARY OF RISK FACTORS

Certain statements in this

Annual Report on Form 10-K (“Annual Report”) may constitute “forward-looking statements” for purposes of

the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management

team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections,

forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements.

The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”

“intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,”

“project,” “should,” “would” and similar expressions may identify forward-looking statements,

but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Annual Report

may include, for example, statements about:

● our ability to select an appropriate target business or businesses;

● our ability to complete our initial business combination;

● our pool of prospective target businesses;

● our public securities’ potential liquidity and trading;

● the lack of a market for our securities;

● the trust account not being subject to claims of third parties; or

● our financial performance.

The forward-looking statements

contained in this Annual Report are based on our current expectations and beliefs concerning future developments and their potential effects

on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements

involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or

performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties

include, but are not limited to, those factors described under the section of this Annual Report entitled “Risk Factors”.

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary

in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any

forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable

securities laws.

ii

Summary of Risk Factors

An investment in our securities

involves a high degree of risk. The occurrence of one or more of the events or circumstances described in the section titled “Risk

Factors,” alone or in combination with other events or circumstances, may materially adversely affect our business, financial

condition and operating results. In that event, the trading price of our securities could decline, and you could lose all or part of your

investment. Such risks include, but are not limited to:

iii

iv

PART I

ITEM 1. BUSINESS

In this Annual Report on

Form 10-K (the “Form 10-K”), references to the “Company” and to “we,” “us,” and “our”

refer to Vickers Vantage Corp. I.

We are a Cayman Islands company

incorporated on February 21, 2020 as an exempted company with limited liability for the purpose of effecting a merger, share exchange,

asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities

(the “Business Combination”). Our efforts to identify a prospective target business will not be limited to a particular industry

or geographic region.

The registration statement

for our initial public offering was declared effective on January 6, 2021. On January 11, 2021, we consummated the initial public offering

of 13,800,000 units (each, a “Unit” and collectively, the “Units”) at $10.00 per Unit, including 1,800,000 units

subject to the underwriters’ over-allotment option. Each Unit consists of one ordinary share, $.0001 par value (“Ordinary

Shares”), of the Company, and one-half of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles

the holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment.

Simultaneously with the closing

of the initial public offering, we consummated the private placement (the “Private Placement”) of 6,840,000 warrants (each,

a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $0.75 per Private

Placement Warrant, generating gross proceeds of $5,130,000. The Private Placement Warrants were purchased by the Company’s sponsors

(the “Sponsors”), Vickers Venture Fund VI Pte Ltd and Vickers Venture Fund VI (Plan) Pte Ltd. Each Private Placement Warrant

is exercisable for one ordinary share at a price of $11.50 per share.

On January 6, 2022, the Sponsors

deposited an aggregate of $1,035,000 into the trust account established in connection with the Company’s initial public offering

(“Trust Account”). The deposit was required to provide the Company an additional three months to consummate an initial business

combination pursuant to the Company’s Amended and Restated Memorandum and Articles of Association. The Company now has until April

11, 2022 to consummate an initial business combination.

$140,415,000 ($10.175 per

public share) is held in the Trust Account, and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16)

of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a

money market fund selected by the Company meeting the conditions of paragraph (d) of Rule 2a-7 of the Investment Company Act, as determined

by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account.

Recent Events

On December 5, 2021, the Company

executed a letter of intent for a potential business combination with Scilex Holding Company, a majority-owned subsidiary of Sorrento

Therapeutics, Inc. (Nasdaq: SRNE) (“Scilex”). The Company is currently negotiating the definitive agreement for such transaction.

There is no assurance that an agreement will be executed. The remainder of this Annual Report on Form 10-K assumes the parties will not

reach an agreement.

Effecting a Business Combination

General

Aside from the activity required

to duly prepare for and effectuate a potential business combination, we are not presently engaged in, and we will not engage in, any substantive

commercial business for an indefinite period of time. We intend to utilize cash derived from the proceeds of our initial public offering

and the private placement of Private Placement Warrants, our capital stock, debt or a combination of these in effecting a business combination.

Although substantially all of the net proceeds of the initial public offering and the private placement of Private Placement Warrants

are intended to be applied generally toward effecting a business combination, the proceeds are not otherwise being designated for any

more specific purposes. A business combination may involve the acquisition of, or merger with, a company which does not need substantial

additional capital but which desires to establish a public trading market for its shares, while avoiding what it may deem to be adverse

consequences of undertaking a public offering itself. These include time delays, significant expense, loss of voting control and compliance

with various Federal and state securities laws. In the alternative, we may seek to consummate a business combination with a company that

may be financially unstable or in its early stages of development or growth. While we may seek to effect simultaneous business combinations

with more than one target business, we will probably have the ability, as a result of our limited resources, to effect only a single business

combination.

1

Sources of Target Businesses

Target business candidates

may be brought to our attention from various unaffiliated sources, including investment bankers and private investment funds. Target businesses

may be brought to our attention by such unaffiliated sources as a result of being solicited by us through calls or mailings. These sources

may also introduce us to target businesses in which they think we may be interested on an unsolicited basis, since many of these sources

will have read this annual report and know what types of businesses we are targeting. Our officers and directors, as well as their affiliates,

and our other shareholders may also bring to our attention target business candidates that they become aware of through their business

contacts as a result of formal or informal inquiries or discussions they may have, as well as attending trade shows or conventions. In

addition, we expect to receive a number of proprietary deal flow opportunities that would not otherwise necessarily be available to us

as a result of the track record and business relationships of our officers and directors. We may also determine to engage the services

of professional firms or other individuals that specialize in business acquisitions on a formal basis, in which event we may pay a finder’s

fee, consulting fee or other compensation to be determined in an arm’s length negotiation based on the terms of the transaction.

If we decide to enter into a business combination with a target business that is affiliated with our officers, directors or initial shareholders,

we will do so only if we have obtained an opinion from an independent investment banking firm or another independent entity that commonly

renders valuation opinions that the business combination is fair to our unaffiliated shareholders from a financial point of view.

Selection of a Target Business and Structuring

of a Business Combination

Subject to the limitations

that a target business have a fair market value of at least 80% of the balance in the Trust Account (excluding deferred underwriting fees

and taxes payable on the income earned on the trust account) at the time of the execution of a definitive agreement for our initial business

combination, as described below in more detail, our management will have virtually unrestricted flexibility in identifying and selecting

a prospective target business. We have not established any other specific attributes or criteria (financial or otherwise) for prospective

target businesses. In evaluating a prospective target business, our management may consider a variety of factors, including one or more

of the following:

● financial condition and results of operation;

● growth potential;

● brand recognition and potential;

● experience and skill of management and availability of additional personnel;

● capital requirements;

● competitive position;

● barriers to entry;

● stage of development of the products, processes or services;

2

● existing distribution and potential for expansion;

● impact of regulation on the business;

● regulatory environment of the industry;

● costs associated with effecting the business combination;

● macro competitive dynamics in the industry within which the company competes.

These criteria are not intended

to be exhaustive. Any evaluation relating to the merits of a particular business combination will be based, to the extent relevant, on

the above factors as well as other considerations deemed relevant by our management in effecting a business combination consistent with

our business objective. In evaluating a prospective target business, we will conduct an extensive due diligence review which will encompass,

among other things, meetings with incumbent management and inspection of facilities, as well as review of financial and other information

which is made available to us. This due diligence review will be conducted either by our management or by unaffiliated third parties we

may engage, although we have no current intention to engage any such third parties.

The time and costs required

to select and evaluate a target business and to structure and complete the business combination cannot presently be ascertained with any

degree of certainty. Any costs incurred with respect to the identification and evaluation of a prospective target business with which

a business combination is not ultimately completed will result in a loss to us and reduce the amount of capital available to otherwise

complete a business combination.

Fair Market Value of Target Business

Pursuant to Nasdaq listing

rules, the target business or businesses that we acquire must collectively have a fair market value equal to at least 80% of the balance

of the funds in the trust account (excluding deferred underwriting fees and taxes payable on the income earned on the trust account) at

the time of the execution of a definitive agreement for our initial business combination, although we may acquire a target business whose

fair market value significantly exceeds 80% of the trust account balance. We currently anticipate structuring a business combination to

acquire 100% of the equity interests or assets of the target business or businesses. We may, however, structure a business combination

where we merge directly with the target business or where we acquire less than 100% of such interests or assets of the target business

in order to meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such

business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or

otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under

the Investment Company Act of 1940, as amended. Even if the post-transaction company owns or acquires 50% or more of the voting securities

of the target, our shareholders prior to the business combination may collectively own a minority interest in the post-transaction company,

depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction

in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In this case, we

would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of new shares, our

shareholders immediately prior to our initial business combination could own less than a majority of our outstanding shares subsequent

to our initial business combination. If less than 100% of the equity interests or assets of a target business or businesses are owned

or acquired by the post-transaction company, only the portion of such business or businesses that is owned or acquired is what will be

valued for purposes of the 80% fair market value test. In order to consummate such an acquisition, we may issue a significant amount of

our debt or equity securities to the sellers of such businesses and/or seek to raise additional funds through a private offering of debt

or equity securities. Since we have no specific business combination under consideration, we have not entered into any such fundraising

arrangement and have no current intention of doing so. The fair market value of the target will be determined by our board of directors

based upon one or more standards generally accepted by the financial community (such as actual and potential sales, earnings, cash flow

and/or book value). If our board is not able to independently determine that the target business has a sufficient fair market value, we

will obtain an opinion from an unaffiliated, independent investment banking firm, or another independent entity that commonly renders

valuation opinions, with respect to the satisfaction of such criteria. We will not be required to obtain an opinion from an independent

investment banking firm, or another independent entity that commonly renders valuation opinions, as to the fair market value if our board

of directors independently determines that the target business complies with the 80% threshold.

3

Lack of Business Diversification

Our business combination must

be with a target business or businesses that collectively satisfy the minimum valuation standard at the time of such acquisition, as discussed

above, although this process may entail the simultaneous acquisitions of several operating businesses at the same time. Therefore, at

least initially, the prospects for our success may be entirely dependent upon the future performance of a single business. Unlike other

entities which may have the resources to complete several business combinations of entities operating in multiple industries or multiple

areas of a single industry, it is probable that we will not have the resources to diversify our operations or benefit from the possible

spreading of risks or offsetting of losses. By consummating a business combination with only a single entity, our lack of diversification

may:

If we determine to simultaneously

acquire several businesses and such businesses are owned by different sellers, we will need for each of such sellers to agree that our

purchase of its business is contingent on the simultaneous closings of the other acquisitions, which may make it more difficult for us,

and delay our ability, to complete the business combination. With multiple acquisitions, we could also face additional risks, including

additional burdens and costs with respect to possible multiple negotiations and due diligence investigations (if there are multiple sellers)

and the additional risks associated with the subsequent assimilation of the operations and services or products of the acquired companies

in a single operating business.

Limited Ability to Evaluate the Target Business’

Management

Although we intend to scrutinize

the management of a prospective target business when evaluating the desirability of effecting a business combination, we cannot assure

you that our assessment of the target business’ management will prove to be correct. In addition, we cannot assure you that the

future management will have the necessary skills, qualifications or abilities to manage a public company. Furthermore, the future role

of our officers and directors, if any, in the target business following a business combination cannot presently be stated with any certainty.

While it is possible that some of our key personnel will remain associated in senior management or advisory positions with us following

a business combination, it is unlikely that they will devote their full time efforts to our affairs subsequent to a business combination.

Moreover, they would only be able to remain with the company after the consummation of a business combination if they are able to negotiate

employment or consulting agreements in connection with the business combination. Such negotiations would take place simultaneously with

the negotiation of the business combination and could provide for them to receive compensation in the form of cash payments and/or our

securities for services they would render to the company after the consummation of the business combination. Additionally, our officers

and directors may not have significant experience or knowledge relating to the operations of the particular target business.

4

Following a business combination,

we may seek to recruit additional managers to supplement the incumbent management of the target business. We cannot assure you that we

will have the ability to recruit additional managers, or that any such additional managers we do recruit will have the requisite skills,

knowledge or experience necessary to enhance the incumbent management.

Shareholders May Not Have the Ability to Approve

an Initial Business Combination

In connection with any proposed

business combination, we will either (1) seek shareholder approval of our initial business combination at a meeting called for such purpose

at which shareholders may seek to redeem their shares, regardless of whether they vote for or against the proposed business combination,

into their pro rata share of the aggregate amount then on deposit in the trust account (net of taxes payable), or (2)

provide our shareholders with the opportunity to sell their shares to us by means of a tender offer (and thereby avoid the need for a

shareholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the trust account

(net of taxes payable), in each case subject to the limitations described herein. If we determine to engage in a tender offer, such tender

offer will be structured so that each shareholder may tender all of his, her or its shares rather than some pro rata portion

of his, her or its shares. The decision as to whether we will seek shareholder approval of a proposed business combination or will allow

shareholders to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety

of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek shareholder

approval. In the case of a tender offer, we will file tender offer documents with the SEC which will contain substantially the same financial

and other information about the initial business combination as is required under the SEC’s proxy rules. We will consummate our

initial business combination only if we have net tangible assets of at least $5,000,001 upon such consummation and, if we seek shareholder

approval, a majority of the outstanding ordinary shares voted are voted in favor of the business combination.

Submission of Our Initial Business Combination

to a Shareholder Vote

In the event that we seek

shareholder approval of our initial business combination, we will distribute proxy materials and, in connection therewith, provide our

public shareholders with the redemption rights described above upon completion of the initial business combination.

If we seek shareholder approval,

we will complete our initial business combination only if we receive an ordinary resolution under Cayman Islands law, which requires the

affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. A quorum for such meeting

will be present if the holders of a majority of issued and outstanding shares entitled to vote at the meeting are represented in person

or by proxy. Our initial shareholders will count toward this quorum and, pursuant to that certain letter agreement, our Sponsor, officers

and directors have agreed to vote their Founder Shares and any public shares purchased during or after the Public Offering (including

in open market and privately-negotiated transactions) in favor of our initial business combination. Each public shareholder may elect

to redeem their public shares irrespective of whether they vote for or against the proposed transaction or whether they were a public

shareholder on the record date for the shareholder meeting held to approve the proposed transaction. Our amended and restated memorandum

and articles of association require that at least five days’ notice will be given of any such shareholder meeting.

Redemption Rights

At any meeting called to approve

an initial business combination, public shareholders may seek to redeem their shares, regardless of whether they vote for or against the

proposed business combination, or do not vote at all, their pro rata share of the aggregate amount then on deposit in

the trust account as of two business days prior to the consummation of the initial business combination, less any taxes then due but not

yet paid. Alternatively, we may provide our public shareholders with the opportunity to sell their ordinary shares to us through a tender

offer (and thereby avoid the need for a shareholder vote) for an amount equal to their pro rata share of the aggregate

amount then on deposit in the trust account, less any taxes then due but not yet paid.

Notwithstanding the foregoing,

a public shareholder, together with any affiliate of his or any other person with whom he is acting in concert or as a “group”

(as defined in Section 13(d)(3) of the Exchange Act) will be restricted from seeking redemption rights with respect to 20% or more of

the shares sold in the Initial Public Offering. Such a public shareholder would still be entitled to vote against a proposed business

combination with respect to all shares owned by him or his affiliates.

5

Liquidation if No Business Combination

Our amended and restated memorandum

and articles of association originally provided that we had 12 months from the closing of our initial public offering to consummate an

initial business combination. However, if we anticipated that we may not be able to consummate our initial business combination within

such period, we had the ability to extend such time period by up to three months on two occasions as described below. On January 6, 2022,

our Sponsors caused us to extend the period of time to consummate an initial business combination until April 11, 2022.

If we are unable to complete

our initial business combination by April 11, 2022 (or, upon one further extension of such period as permitted by the our amended and

restated memorandum and articles of association, as further described below, by July 11, 2022), we will (i) cease all operations except

for the purpose of winding up, (ii) as promptly as reasonably possible but not more than five business days thereafter, redeem 100% of

the outstanding public shares which redemption will completely extinguish public shareholders’ rights as shareholders (including

the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible

following such redemption, subject to the approval of our remaining holders of ordinary shares and our board of directors, proceed to

commence a voluntary liquidation and thereby a formal dissolution of the company, subject (in the case of (ii) and (iii) above) to our

obligations to provide for claims of creditors and the requirements of applicable law.

As indicated above, our amended

and restated memorandum and articles of association provides that if we anticipate that we may not be able to consummate our initial business

combination within the period allowed after the closing of our initial public offering, we may, by resolution of our board if requested

by our sponsors, extend the period of time to consummate a business combination up to once more, by an additional three months (for a

total of up to 18 months after the closing of our initial public offering to complete a business combination), subject to the Sponsors

depositing additional funds into the trust account as set forth below. Our shareholders will not be entitled to vote or redeem their shares

in connection with any such extensions. Pursuant to the terms of our amended and restated memorandum and articles of association and the

trust agreement entered into between us and Continental Stock Transfer & Trust Company, in order for the time available for us

to consummate our initial business combination to be extended, our sponsor or its affiliates or designees must deposit into the trust

account $1,035,000 ($0.075 per share), on or prior to the date of the deadline, for the available three month extension providing a total

possible business combination period of 18 months for a total payment value of $2,070,000 ($0.15 per share). Any such deposits will be

in the form of non-interest-bearing loans to us. If we complete our initial business combination, we will, at the option of our sponsors,

repay such loaned amounts or convert a portion or all of the total loan amount into warrants at a price of $0.75 per warrant, which warrants

will be identical to the private warrants. If we do not complete a business combination, we will repay such loans only from funds held

outside of the trust account. Furthermore, the letter agreement with our initial shareholders contains a provision pursuant to which our

sponsors have agreed to waive their right to be repaid for such loans to the extent there is insufficient funds held outside of the trust

account in the event that we do not complete a business combination. Our sponsors and their affiliates or designees are not obligated

to fund the trust account to extend the time for us to complete our initial business combination.

If we are unable to complete

our initial business combination within the allotted time period, we may propose to amend our amended and restated memorandum and articles

of association to modify the timing by which we must consummate our initial business combination, which proposal must be approved by our

shareholders. In such event, our public shareholders shall be entitled to receive funds from the trust account if they redeem their shares

in connection with such shareholder vote.

In connection with our redemption

of 100% of our issued and outstanding public shares for a portion of the funds held in the trust account, each public shareholder will

receive a full pro rata portion of the amount then in the trust account, plus any pro rata interest earned on the funds held in the trust

account and not previously released to us and less up to $50,000 for liquidation expenses. Holders of warrants will receive no proceeds

in connection with the liquidation with respect to such warrants, which will expire worthless.

6

Competition

In identifying, evaluating

and selecting a target business, we may encounter intense competition from other entities having a business objective similar to ours.

Many of these entities are well established and have extensive experience identifying and effecting business combinations directly or

through affiliates. Many of these competitors possess greater technical, human and other resources than us and our financial resources

will be relatively limited when contrasted with those of many of these competitors. Our ability to compete in acquiring certain sizable

target businesses may be limited by our available financial resources.

The following also may not

be viewed favorably by certain target businesses:

In recent years, and especially

since the fourth quarter of 2020, the number of special purpose acquisition companies that have been formed has increased substantially.

Many potential targets for special purpose acquisition companies have already entered into an initial business combination, and there

are still many special purpose acquisition companies seeking targets for their initial business combination, as well as many such companies

currently in registration. As a result, at times, fewer attractive targets may be available, and it may require more time, more effort

and more resources to identify a suitable target and to consummate an initial business combination.

If we succeed in effecting

a business combination, there in all likelihood will be intense competition from competitors of the target business. We cannot assure

you that subsequent to a business combination we will have the resources or ability to compete effectively.

Employees

We have two executive officers.

These individuals are not obligated to devote any specific number of hours to our matters and intend to devote only as much time as they

deem necessary to our affairs. The amount of time they will devote in any time period will vary based on whether a target business has

been selected for the business combination and the stage of the business combination process the company is in. Accordingly, once management

locates a suitable target business to acquire, they will spend more time investigating such target business and negotiating and processing

the business combination (and consequently spend more time to our affairs) than they would prior to locating a suitable target business.

We presently expect each of our executive officers to devote such amount of time as they reasonably believe is necessary to our business.

We do not intend to have any full time employees prior to the consummation of a business combination.

Facilities

We currently maintain our

executive offices at 1 Harbourfront Avenue, #16-06, Keppel Bay Tower, Singapore 098632, Singapore. Such space, utilities and secretarial

and administrative services will be provided to us free of charge by an affiliate of our executive officers. We consider our current office

space adequate for our current operations.

7

ITEM 1A. RISK FACTORS

An

investment in our securities involves a high degree of risk. You should consider carefully all of the risks described below, together

with the other information contained in this Annual Report on Form 10-K, the prospectus associated with our Initial Public Offering

and the registration statement of which such prospectus forms a part, before making a decision to invest in our securities, before making

a decision to invest in our units. If any of the following events occur, our business, financial condition and operating results may be

materially adversely affected. In that event, the trading price of our securities could decline, and you could lose all or part of your

investment.

Risks Relating to

Business Operations and Searching for and Consummating a Business Combination

We have no operating history and no revenues, and you have no basis

on which to evaluate our ability to achieve our business objective.

We

have no operating results. To date, our only activities have been related to our formation and the IPO and the search and evaluation

of potential targets in contemplation of a business combination. Because we lack an operating history, you have no basis upon which to

evaluate our ability to achieve our business objective of completing our initial business combination with one or more target businesses.

If we fail to complete our initial business combination, we will never generate any operating revenues.

Our independent registered public accounting firm’s report

contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.”

As

of December 31, 2021, we had $507,921 in cash held outside of the trust account and working capital of $375,253. Further, we have incurred

and expect to continue to incur significant costs in pursuit of our finance and acquisition plans. The Company’s business plan

is dependent on the completion of a business combination and the Company’s cash and working capital as of December 31, 2021 are

not sufficient to complete its planned activities. These conditions raise substantial doubt about the Company’s ability to continue

as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. We

cannot assure you that we will consummate an initial business combination or that we will have sufficient cash available to allow us

to complete our initial business combination.

We identified a material weakness in our internal control

over financial reporting as of September 30, 2021 and as of March 31, 2021. If we are unable to develop and maintain an effective system

of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which

may adversely affect investor confidence in us and materially and adversely affect our business and operating results.

The

Company reported a material weakness in its Quarterly Report on Form 10-Q/A for the quarter ended September 30, 2021, as management identified

a material weakness in our internal control over financial reporting related to the Company’s accounting and reporting of complex

financial instruments, including application of ASC 480-10-S99-3A to its accounting classification of public shares. As a result of this

material weakness, our management has concluded that our disclosure controls and procedures were not effective as of September 30, 2021.

We have taken a number of measures to remediate the material weaknesses described herein. However, if we are unable to remediate our

material weaknesses in a timely manner or we identify additional material weaknesses, we may be unable to provide required financial

information in a timely and reliable manner and we may incorrectly report financial information. Likewise, if our financial statements

are not filed on a timely basis, we could be subject to sanctions or investigations by the stock exchange on which our ordinary shares

are listed, the SEC or other regulatory authorities. The existence of material weaknesses in internal control over financial reporting

could adversely affect our reputation or investor perceptions of us, which could have a negative effect on the trading price of our shares.

We can give no assurance that the measures we have taken and plan to take in the future will remediate the material weakness identified

or that any additional material weaknesses or restatements of financial results will not arise in the future due to a failure to implement

and maintain adequate internal control over financial reporting or circumvention of these controls. Even if we are successful in strengthening

our controls and procedures, in the future those controls and procedures may not be adequate to prevent or identify irregularities or

errors or to facilitate the fair presentation of our financial statements.

The Company also reported a material weakness in its Quarterly Report

on Form 10-Q for the quarter ended March 31, 2021 as management determined our internal control over financial reporting did not result

in the proper accounting for complex financial instruments, in that the classification of the private placement warrants we issued in

January 2021 were recorded as equity and not liabilities.

8

A material weakness is a deficiency, or a combination of deficiencies,

in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or

interim financial statements will not be prevented, or detected and corrected on a timely basis.

Effective internal controls are necessary for us to provide reliable

financial reports and prevent fraud. We continue to evaluate steps to remediate the material weakness. These remediation measures may

be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended effects.

If we identify any new material weaknesses in the future, any such

newly identified material weakness could limit our ability to prevent or detect a misstatement of our accounts or disclosures that could

result in a material misstatement of our annual or interim financial statements. In such case, we may be unable to maintain compliance

with securities law requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements,

investors may lose confidence in our financial reporting and our stock price may decline as a result. We cannot assure you that the measures

we have taken to date, or any measures we may take in the future, will be sufficient to avoid potential future material weaknesses.

The requirement that

we complete our initial business combination within 15 months from the closing of the Initial Public Offering (or 18 months from the closing

of the Initial Public Offering if we have extended the period of time to consummate an initial business combination as described herein)

may give potential target businesses leverage over us in negotiating our initial business combination and may limit the amount of time

we have to conduct due diligence on potential business combination targets as we approach our dissolution deadline, which could undermine

our ability to consummate our initial business combination on terms that would produce value for our shareholders.

Any

potential target business with which we enter into negotiations concerning our initial business combination will be aware that we must

consummate our initial business combination within 15 months from the closing of the Initial Public Offering (or up to 18 months from

the closing of the Initial Public Offering if we have further extended the period of time to consummate an initial business combination

as described herein). Consequently, such target businesses may obtain leverage over us in negotiating our initial business combination,

knowing that if we do not complete our initial business combination with that particular target business, we may be unable to complete

our initial business combination with any target business. This risk will increase as we get closer to the timeframe described above.

In addition, we may have limited time to conduct due diligence and may enter into our initial business combination on terms that we would

have rejected upon a more comprehensive investigation.

We may not be able

to consummate our initial business combination within the required time period, in which case we would cease all operations except for

the purpose of winding up and we would redeem our public shares and liquidate.

We

must complete our initial business combination within 15 months from the closing of the Initial Public Offering (or up to 18 months from

the closing of the Initial Public Offering if we have further extended the period of time to consummate an initial business combination

as described herein). We may not be able to find a suitable target business and consummate our initial business combination within such

time period. Our ability to complete our initial business combination may be negatively impacted by general market conditions, volatility

in the capital and debt markets and the other risks described herein. If we are unable to consummate our initial business combination

within the required time period, we will, as promptly as reasonably possible but not more than five business days thereafter, distribute

the aggregate amount then on deposit in the trust account (net of taxes payable, and less up to $50,000 of interest to pay liquidation

expenses), pro rata to our public shareholders by way of redemption and cease all operations except for the purposes of winding up of

our affairs, as further described herein. This redemption of public shareholders from the trust account shall be effected as required

by function of our memorandum and articles of association and prior to any voluntary winding up.

Our public shareholders

will not be entitled to vote or redeem their shares in connection with either of our potential three-month extensions.

If

we are not able to consummate our initial business combination within 15 months, we may, by resolution of our board if requested by our

Sponsors, extend the period of time to consummate a business combination by an additional three months, as long as our Sponsors or their

affiliates or designees, prior to the deadline, deposits into the trust account $1,035,000 ($0.075 per unit,) on or prior to the date

of the deadline, for the three-month extension. Our public shareholders will not be entitled to vote or redeem their shares in connection

with any such extension. As a result, we may conduct such an extension even though a majority of our public shareholders do not support

such an extension and will not be able to redeem their shares in connection therewith. This feature is different than the traditional

special purpose acquisition company structure, in which any extension of the company’s period to complete a business combination

requires a vote of the company’s shareholders and shareholders have the right to redeem their public shares in connection with such

vote.

9

Our Sponsors may decide

not to extend the term we have to consummate our initial business combination, in which case we would cease all operations except for

the purpose of winding up and we would redeem our public shares and liquidate, and the warrants will be worthless.

We

have until 15 months from the closing of the Initial Public Offering to consummate our initial business combination. However, if we anticipate

that we may not be able to consummate our initial business combination within 15 months, we may, by resolution of our board if requested

by our Sponsors, extend the period of time to consummate a business combination once more, by an additional three months (for a total

of up to 18 months to complete a business combination), subject to the Sponsors depositing additional funds into the trust account. Our

shareholders will not be entitled to vote or redeem their shares in connection with any such extension. However, our shareholders will

be entitled to vote and redeem their shares in connection with a shareholder meeting held to approve an initial business combination or

in a tender offer undertaken in connection with an initial business combination if we propose such a business combination during any three-month

extension period. In order for the time available for us to consummate our initial business combination to be extended, our Sponsors or

their affiliates or designees must deposit into the trust account $1,035,000 ($0.075 per unit) for the three month extension. Any such

deposits will be in the form of non-interest-bearing loans to us. If we complete our initial business combination, we will, at the option

of our Sponsors, repay such loaned amounts or redeem a portion or all of the total loan amount into warrants at a price of $0.75 per warrant,

which warrants will be identical to the private warrants. If we do not complete a business combination, we will repay such loans only

from funds held outside of the trust account. Our Sponsors and their affiliates or designees are not obligated to fund the trust account

to extend the time for us to complete our initial business combination. If we are unable to consummate our initial business combination

within the applicable time period, we will liquidate as described herein. In such event, the warrants will be worthless.

If we are unable to

consummate our initial business combination within 15 months of the closing of the Initial Public Offering (or up to 18 months if the

time to consummate an initial business combination has been extended as described above), our public shareholders may be forced to wait

beyond such period of time before redemption from our trust account.

If

we are unable to consummate our initial business combination within 15 months from the closing of the Initial Public Offering (or up to

18 months if the time to consummate an initial business combination has been further extended as described above), we will, as promptly

as reasonably possible but not more than five business days thereafter, distribute the aggregate amount then on deposit in the trust account

(net of taxes payable, and less up to $50,000 of interest to pay liquidation expenses), pro rata to our public shareholders by way of

redemption and cease all operations except for the purposes of winding up of our affairs by way of a voluntary liquidation, as further

described herein. Any redemption of public shareholders from the trust account shall be effected as required by our memorandum and articles

of association prior to our commencing any voluntary liquidation. If we are required to liquidate prior to distributing the aggregate

amount then on deposit in the trust account (net of taxes payable, and less up to $50,000 of interest to pay liquidation expenses) pro

rata to our public shareholders, then such winding up, liquidation and distribution must comply with the applicable provisions of the

Companies Act. In that case, investors may be forced to wait beyond 15 months (or up to 18 months if we extend the period of time to consummate

an initial business combination as described above) before the redemption proceeds of our trust account become available to them, and

they receive the return of their pro rata portion of the proceeds from our trust account. Except as otherwise described herein, we have

no obligation to return funds to investors prior to the date of any redemption required as a result of our failure to consummate our initial

business combination within the period described above or our liquidation, unless we consummate our initial business combination prior

thereto and only then in cases where investors have sought to redeem their ordinary shares. Only upon any such redemption of public shares

as we are required to effect or any liquidation will public shareholders be entitled to distributions if we are unable to complete our

initial business combination.

10

Our public shareholders

may not be afforded an opportunity to vote on our proposed business combination, which means we may consummate our initial business combination

even though a majority of our public shareholders do not support such a combination.

If

we do not decide to hold a shareholder vote in conjunction with our initial business combination for business or other legal reasons,

we will conduct redemptions pursuant to the tender offer rules of the SEC and our memorandum and articles of association. Nasdaq rules

currently allow us to engage in a tender offer in lieu of a general meeting, provided that we were not seeking to issue more than 20%

of our issued and outstanding shares to a target business as consideration in any business combination. Furthermore, shareholder approval

would not be required pursuant to the Companies Act if our initial business combination were structured as a purchase of assets, a purchase

of stock, shares or other equity securities of the target not involving a merger with us, or a merger of the target into a subsidiary

of our company, or if we otherwise entered into contractual arrangements with a target to obtain control of such company. Accordingly,

we may consummate our initial business combination even if holders of a majority of our public shares do not approve of the business combination.

Your only opportunity

to affect the investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your

shares from us for cash.

At

the time of your investment in us, you will not be provided with an opportunity to evaluate the specific merits or risks of one or more

target businesses. Because our board of directors may consummate our initial business combination without seeking shareholder approval,

public shareholders may not have the right or opportunity to vote on the business combination. Accordingly, your only opportunity to affect

the investment decision regarding a potential business combination may be limited to exercising your redemption rights within the period

of time (which will be at least 20 business days) set forth in our tender offer documents mailed to our public shareholders in which we

describe our initial business combination.

If we seek shareholder

approval of our business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group”

of shareholders are deemed to hold in excess of 20% of our ordinary shares, you will lose the ability to redeem all such shares in excess

of 20% of our ordinary shares.

If

we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our business combination

pursuant to the tender offer rules, our memorandum and articles of association provides that a public shareholder, individually or together

with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group”

(as defined under Section 13 of the Exchange Act), will be restricted from seeking redemption rights with respect to more than an aggregate

of 20% of the shares sold in the Initial Public Offering. Your inability to redeem more than an aggregate of 20% of the shares sold in

the Initial Public Offering will reduce your influence over our ability to consummate our initial business combination and you could suffer

a material loss on your investment in us if you sell such excess shares in open market transactions. As a result, you will continue to

hold that number of shares exceeding 20% and, in order to dispose of such shares, you would be required to sell your shares in open market

transaction, potentially at a loss.

Our initial shareholders

control a substantial interest in us and thus may exert a substantial influence on actions requiring a shareholder vote, potentially in

a manner that you do not support.

Upon

closing of the Initial Public Offering and the private placement, our initial shareholders own 20% of our issued and outstanding ordinary

shares. Accordingly, they may exert a substantial influence on actions requiring a shareholder vote, potentially in a manner that you

Source: SEC EDGAR (public domain) · 10-K for the period ended 2021-12-31, filed 2022-02-24 · accession 0001213900-22-009229

Filing HTML rendered to line-structured narrative text by the shipped reducer (datafeeds.edgar_fulltext.visible_text, keep_table_headers=True): scripts and inline-XBRL headers are dropped, and table content is reduced to its short label cells — numeric table data is not rendered and is therefore not counted. The same rendering is used for every year, so a year-over-year comparison is like for like.

The text is our rendering of the filing, not a facsimile: original pagination, typography and tables are not reproduced, and the numbers live in the financial statements (FA).

The outline locates item HEADINGS in this document. Only Items 1A and 7 have certified boundaries elsewhere in the terminal (the redline and the narrative-overlap number); every span here runs from one heading found to the next heading found.

How the outline was chosen. It is the longest chain of item headings that runs forward through both the document and the standard item order: 22 headings are on that chain and 17 further heading-shaped lines are not — the table-of-contents echo of every item, cross-references and exhibit-list mentions. Each entry's length is measured from its heading to the next heading on the chain.